Cargando…

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study

BACKGROUND: The T2-FLAIR mismatch sign is an imaging finding highly suggestive of isocitrate dehydrogenase mutated (IDH-mut) 1p19q non-codeleted (non-codel) gliomas (astrocytomas). In previous studies, it has shown excellent specificity but limited sensitivity for IDH-mut astrocytomas. Whether the m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corell, Alba, Ferreyra Vega, Sandra, Hoefling, Nickoleta, Carstam, Louise, Smits, Anja, Olsson Bontell, Thomas, Björkman-Burtscher, Isabella M., Carén, Helena, Jakola, Asgeir Store
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238512/ https://www.ncbi.nlm.nih.gov/pubmed/32434559 http://dx.doi.org/10.1186/s12885-020-06951-w

Ejemplares similares

DNA methylation profiling for molecular classification of adult diffuse lower-grade gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2021)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Longitudinal DNA methylation analysis of adult-type IDH-mutant gliomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2023)

Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015
por: Carstam, Louise, et al.
Publicado: (2019)

Spatial heterogeneity in DNA methylation and chromosomal alterations in diffuse gliomas and meningiomas
por: Ferreyra Vega, Sandra, et al.
Publicado: (2022)

Intratumor DNA methylation heterogeneity in glioblastoma: implications for DNA methylation-based classification
por: Wenger, Anna, et al.
Publicado: (2019)

The clinical value of proneural, classical and mesenchymal protein signatures in WHO 2021 adult-type diffuse lower-grade gliomas
por: Dénes, Anna, et al.
Publicado: (2023)

Stemness and clinical features in relation to the subventricular zone in diffuse lower-grade glioma: an exploratory study
por: Corell, Alba, et al.
Publicado: (2022)

Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period
por: Svenjeby, Caroline, et al.
Publicado: (2022)

Seizures in patients with IDH-mutated lower grade gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

Meningioma classification by immunohistochemistry: A replicability study
por: Näslund, Olivia, et al.
Publicado: (2022)

Preoperative Patient-Reported Outcomes in Suspected Low-Grade Glioma: Markers of Disease Severity and Correlations with Molecular Subtypes
por: Buvarp, Dongni, et al.
Publicado: (2021)

Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study
por: Carstam, Louise, et al.
Publicado: (2019)

Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study
por: Rydén, Isabelle, et al.
Publicado: (2021)

Correction: Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study
por: Rydén, Isabelle, et al.
Publicado: (2022)

Return to work following meningioma surgery: a Swedish nationwide registry-based matched cohort study
por: Thurin, Erik, et al.
Publicado: (2020)

Deep learning for automatic brain tumour segmentation on MRI: evaluation of recommended reporting criteria via a reproduction and replication study
por: Gryska, Emilia, et al.
Publicado: (2022)

Classification of Adverse Events Following Surgery in Patients With Diffuse Lower-Grade Gliomas
por: Gómez Vecchio, Tomás, et al.
Publicado: (2021)

Return to work following diagnosis of low-grade glioma: A nationwide matched cohort study
por: Rydén, Isabelle, et al.
Publicado: (2020)

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas
por: Deguchi, Shoichi, et al.
Publicado: (2020)

The T2‐FLAIR mismatch sign as an imaging biomarker for oligodendrogliomas in dogs
por: Garcia‐Mora, Josefa, et al.
Publicado: (2023)

NI-09 CLINICAL SIGNIFICANCE OF T2-FLAIR MISMATCH SIGN IN LOWER GRADE GLIOMAS
por: Deguchi, Shoichi, et al.
Publicado: (2019)

NI-17 T2-FLAIR MISMATCH SIGN IN DIFFUSE GLIOMA AND DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR
por: Onishi, Shumpei, et al.
Publicado: (2019)

NI-10 T2/FLAIR mismatch sign and methionine PET uptake in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2020)

Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based study
por: Corell, Alba, et al.
Publicado: (2019)

Moving from clinician-defined to patient-reported outcome measures for survivors of high-grade glioma
por: Rosenlund, Lena, et al.
Publicado: (2019)

The T2-FLAIR mismatch sign in glioblastoma, isocitrate dehydrogenase wild-type A case report
por: Nishimura, Shunsuke, et al.
Publicado: (2023)

Is intracranial volume a risk factor for IDH-mutant low-grade glioma? A case–control study
por: Sagberg, Lisa Millgård, et al.
Publicado: (2022)

Perioperative fatigue in patients with diffuse glioma
por: Schei, Stine, et al.
Publicado: (2020)

Shared decision-making in neurosurgery: a scoping review
por: Corell, Alba, et al.
Publicado: (2021)

Amino acid tracers in PET imaging of diffuse low-grade gliomas: a systematic review of preoperative applications
por: Näslund, Olivia, et al.
Publicado: (2018)

The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas
por: Kapsalaki, Eftychia Z., et al.
Publicado: (2020)

DWI-FLAIR Mismatch at MRI Versus Infarct-Penumbra Mismatch on CT Perfusion
por: Collard, Margaux, et al.
Publicado: (2019)

Is there a response shift in generic health-related quality of life 6 months after glioma surgery?
por: Jakola, Asgeir Store, et al.
Publicado: (2016)

Stalled oligodendrocyte differentiation in IDH-mutant gliomas
por: Wei, Yanfei, et al.
Publicado: (2023)

Patterns of care and clinical outcome in assumed glioblastoma without tissue diagnosis: A population-based study of 131 consecutive patients
por: Werlenius, Katja, et al.
Publicado: (2020)

T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology
por: Foltyn, Martha, et al.
Publicado: (2020)

NI-8 Molecular diagnostic prediction combining T2-FLAIR mismatch sign, calcification, and methionine PET in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2021)

Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Lower-Grade Gliomas: An Epidemiological Voxel-Based Analysis of Location and Proximity to Eloquent Regions
por: Gómez Vecchio, Tomás, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2hacbh9k1gkuup2tdkpnb5n4dd